Iranian Journal of Chemistry

Iranian Journal of Chemistry

Sustained release of carboplatin as an anticancer drug from nanocarrier of reduced graphene oxide/albumin nanoparticles: study of behaviour and release mechanism in acidic media

Document Type : Original Article

Authors
Jaber Khodadi
Maryam Saeidifar
Materials and Energy Research Center
10.22036/cr.2020.224855.1118
Abstract
Nanotechnology is a tool to the performance improvement of systems in the medical field. Based on this purpose, reduced graphene oxide nanoparticle/albumin nanoparticles as a drug carrier was chosen for sustained release of anticancer carboplatin. The release behavior, mechanism type of diffusion and other pharmacokinetic parameters were studied. Initially, The size distribution, hydrodynamic diameter and morphology of reduced graphene oxide nanoparticles / albumin nanoparticles (1 to 5 wt.%) were investigated by dynamic light scattering (DLS) and scanning electron microscopy (FESEM). Then, carboplatin was loaded on the carrier and the encapsulation percentage was 50.13% and the drug loading percentage was 48.85%. Drug release behavior in an acidic environment similar to cancer tissue was assessed for 167 h by UV-Vis spectroscopy and it was shown that drug was released slowly. The release mechanism studies were shown that release mechanism followed by Korsmeyer-Pepas and non-Fickian diffusion. Other kinetic parameters such as kinetic constant, rate of release and maximum concentration of released drug were also calculated. We hope that the results can be introducing carrier based on carbon-protein for cancer treatment.

Graphical Abstract

Sustained release of carboplatin as an anticancer drug from nanocarrier of reduced graphene oxide/albumin nanoparticles: study of behaviour and release mechanism in acidic media
Keywords
Drug carrier
Composite reduced graphene oxide/albumin nanoparticles
Carboplatin
Release mechanism
1)       J. Folkman, D.M. Long, J. Surg. Res. 4(3), 139 (1964).
2)       B.Wang, L. Hu, T.J. Siahaan, Drug delivery: principles and applications. John Wiley & Sons (2016).
3)       R. Langer, N.A. Peppas, Biomat. 2(4), 201 (1981).
4)       F. Rezaei, M. Saeidifar, M. Javaheri, P. Sangpour, Col. Surf. B. 171, 10 (2018).
5)       Z. Sheng, L. Song, J. Zheng, D. Hu, M. He, M. Zheng, G. Gao, P. Gong, P. Zhang, Y. Ma, L. Cai, Biomat. 34(21), 5236 (2013).
6)       K. Muthoosamy, R. G Bai, S. Manickam, Curr. Drug Del. 11(6), 701 (2014).
7)       C. McCallion, J. Burthem, K. Rees-Unwin, A. Golovanov, A. Pluen, Europ. J. Pharm. Biopharm. 104, 235 (2016).
8)       X. Sun, Z. Liu, K. Welsher, J.T. Robinson, A. Goodwin, S. Zaric, H. Dai, Nano Res. 1(3), 203 (2008).
9)       G.J. Quinlan, G.S. Martin, T.W. Evans, Hepatology, 41(6), 1211 (2005).
10)    G. Fanali, A. di Masi, V. Trezza, M. Marino, M. Fasano, P. Ascenzi, Mol. Aspect. Med. 33(3), 209 (2012).
11)    F. Kratz, J. control. Release. 132(3), 171 (2008).
12)    A.K. Iyer, G. Khaled, J. Fang, H. Maeda, Drug dis. Today, 11(17), 812 (2006).
13)    K. Greish, Cancer Nanotechnology: Methods and Protocols (2010).
14)    C. Heneweer, J.P. Holland, V. Divilov, S. Carlin, J.S. Lewis, J. Nuc. Med. 52(4), 625 (2011).
15)            M. Goudarzvand, Z. Ataie, Alborz Univers. Med. Sci. J. 7 (3), 220 (2018).
16)    N. Fattahian Kalhor, M. Saeidifar, H. Ramshini, A.A. Saboury, J. Biomol. Struct. Dyn. 1, in press (2019).
17)    K. Westesen, H. Bunjes, M.H.J. Koch, J. Control. Release. 48(2), 223 (1997).
18)    S. Dash, P.N. Murthy, L. Nath, P. Chowdhury, Acta Pol. Pharm. 67(3), 217 (2010).
19)    G.H. Son, B.-J. Lee, C.-W. Cho, J.Pharm. Invest. 47(4), 287 (2017).
20)    J.Y. Jun, H.H. Nguyen, H.S. Chun, B.-C. Kang, S. Ko, Food Chem. 127(4), 1892 (2011).
21)    M. Gaumet, A. Vargas, R. Gurny, F. Delie, Europ. J. Pharm. Biopharm. 69(1), 1 (2008).
22)    Hossein Ayazi, O. Akhavan, M. Raoufi, R. Varshochian, N.S. Hosseini Motlagh, F, Atyabi, Col. Surf. B. 186, 110712 (2020).
23)    A. Pourjavadi, S. Asgari, S.H. Hosseini, J. Drug Del. Sci. Tech. 56, 101542 (2020).
24)    G. Darabdhara, M.R. Das, S.P. Singh, A.K. Rengan, S. Szunerits, R. Boukherroub, Adv. Col. Inter. Sci. 271, 101991 (2019).
25)    T. Zhou, X. Zhou, D. Xing, Biomat. 35 (13), 4185 (2014).
26)    X. Yang, Y. Wang, X. Huang, Y. Ma, Y. Huang, R. Yang, H. Duan,Y. Chen, J. Mater. Chem. 21(10), 3448 (2011).
27)    https://sdbs.db.aist.go.jp/sdbs/cgi-bin/cre_index.cgi.
28)    F. Ahmed, M.J. Ali, A.K. Kondapi, Int. J. Biol. Macromol. 70, 572 (2014).
29)    M. Hassanzadeganroudsari, A. Heydarinasab, M. Soltani, P. Chen, A. Akbarzadehkhiyavi, J. Drug Del. Sci. Tech. 54, 101218 (2019).
30)    X. Zhu, Y. Peng, L. Qiu, Col. Surf. B. 157, 156 (2017).
31)    R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, N.A. Peppas, Int. J.Pharm. 15(1), 25 (1983).
32)    Y. Fu, W.J. Kao, Expert. Opin. Drug Deliv. 7(4), 429 (2010).
Iranian Journal of Chemistry
Volume 3, Issue 2 - Serial Number 5
March 2021
Pages 203-212

  • Receive Date 30 December 2020
  • Revise Date 25 May 2020
  • Accept Date 01 May 2020